Nasir Ahmad

Peshawar, KP, Pakistan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Correction: Emodin, a Potent Anthraquinone Mitigates MPTP-Induced Parkinsons' Disease Pathology by Regulating Nrf2 and Its Downstream Targets: In Silico and In Vivo Approach.

Correction: Emodin, a Potent Anthraquinone Mitigates MPTP-Induced Parkinsons' Disease Pathology by Regulating Nrf2 and Its Downstream Targets: In Silico and In Vivo Approach.

Journal: Molecular neurobiology

Published: May 27, 2025

Emodin, a Potent Anthraquinone Mitigates MPTP-Induced Parkinsons' Disease Pathology by Regulating Nrf2 and Its Downstream Targets: In Silico and In Vivo Approach.

Emodin, a Potent Anthraquinone Mitigates MPTP-Induced Parkinsons' Disease Pathology by Regulating Nrf2 and Its Downstream Targets: In Silico and In Vivo Approach.

Journal: Molecular neurobiology

Published: September 04, 2024

Isolation, characterization and pharmacological investigations of secondary metabolites from Aspergillus ficuum via experimental and computational techniques.

Isolation, characterization and pharmacological investigations of secondary metabolites from Aspergillus ficuum via experimental and computational techniques.

Journal: RSC advances

Published: May 18, 2024

In silico evaluation of favipiravir-associated potential new drugs against polymerase enzyme of SARS-CoV-2.

In silico evaluation of favipiravir-associated potential new drugs against polymerase enzyme of SARS-CoV-2.

Journal: Heliyon

Published: May 02, 2024

Effectiveness Of Pcr Pool Testing For Screening Of Covid-19 Infection In Pakistan.

Effectiveness Of Pcr Pool Testing For Screening Of Covid-19 Infection In Pakistan.

Journal: Journal of Ayub Medical College, Abbottabad : JAMC

Published: December 25, 2022

Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients.

Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients.

Journal: Pakistan journal of pharmaceutical sciences

Published: January 18, 2022

Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2.

Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2.

Journal: Journal of molecular structure

Published: May 17, 2021

Research developments in the syntheses, anti-inflammatory activities and structure-activity relationships of pyrimidines.

Research developments in the syntheses, anti-inflammatory activities and structure-activity relationships of pyrimidines.

Journal: RSC advances

Published: December 19, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026